0R0T

Amgen Inc. · LSE:0R0T

466.85 USD7.90 +1.72%

Amgen Inc. (LSE:0R0T) last traded at 466.85 USD, up 1.72% on the day. Over the past year the stock is up 61.09%. Its 52-week range is 291.22 to 475.14. It is in the Health Technology sector (Biotechnology).

Key statistics

Open468.01

Day range464.40 – 475.14

52-week range291.22 – 475.14

Volume8.95 K

Average volume (10 days)3.18 K

Market cap251.94 B

P/E29.00

EPS (TTM)16.10

Dividend yield2.13%

Beta (1 year)1.12

Revenue (TTM)38.20 B

Employees31.50 K

Performance

+4.45%1 week

+8.70%1 month

+21.90%3 months

+37.03%6 months

+42.71%Year to date

+61.09%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

405.32 USD

The average 1-year price target, −13.18% from the last price. See the forecast

Latest headlines

Amgen (AMGN) reports Q3: everything you need to know ahead of earningsStock Story · 02 Nov 2026
Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on CancerBenzinga · 29 Oct 2026
Amgen Q3 Earnings: Will Strong Drug Sales Offset Headwinds?Zacks · 28 Oct 2026
FDA warns Amgen over cancer drug promotional videoReuters · 28 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.